References

Geneva: WHO; 1999
: The Royal College of Physicians; 2004
Rhodes CJ Type 2 diabetes – a matter of b-cell life and death?. Science. 2005; 307:380-384
Holt TA, Stables D, Hippisley-Cox J Identifying undiagnosed diabetes: cross-sectional survey of 3.6 million patients' electronic records. Br J Gen Pract. 2008; 58:192-196
International Diabetes Federation. 2009. http://www.diabetesatlas.org
Pickup JC, Williams G Genetic counselling in diabetes mellitus, 3rd edn. Oxford: Blackwell Science; 2003
Mealey BL, Ocampo GL Diabetes mellitus and periodontal disease. Periodontology 2000. 2007; 44:127-153
Kumar P, Clark M, 6th edn. Edinburgh: WB Saunders; 2005
Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivim ki M Prediabetes: a high-risk state for diabetes development. The Lancet. 2012; 16:(9833)2279-2290
Bownlee M The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54:(6)1615-1625
: The Royal College of Physicians; 2008
Ship JA Diabetes and oral health: an overview. J Am Dent Assoc. 2003; 134:(1)4S-10S
Twetman S, Johansson I, Birkhed D, Nederfors T Caries incidence in young type 1 diabetes mellitus patients in relation to metabolic control and caries-associated risk factors. Caries Res. 2002; 36:31-35
Wilson RM, Reeves WG Neutrophil function in diabetes. In: Nattrass M (ed). Edinburgh: Churchill Livingstone; 1986
Hostetter MK Perspectives in diabetes. Handicaps to host defense: effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990; 39:271-275
Darwazeh AMG, MacFarlane TW, McCuish A, Lamey P-J Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med. 1991; 20:280-283
Campus G, Salem A, Uzzau S, Baldoni E, Tonolo G Diabetes and periodontal disease: a case-control study. J Periodontol. 2005; 76:418-425
Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S Monocytic TNF-a secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol. 1997; 24:8-16
Diabetes and periodontal infection: making the connection. Clinical Diabetes. 2005; 23:(4)171-178
Iacopino AM Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol. 2001; 6:(1)125-137
Alexander RE Routine prophylactic antibiotic use in diabetic dental patients. J Cal Dent Assoc. 1999; 8:611-618
Standards for Clinical Practice and Training for Dental Practitioners and Dental Care Professionals in General Dental Practice: A Statement from The Resuscitation Council (UK). 2006;

Diabetes mellitus: considerations for the dental practitioner

From Volume 41, Issue 2, March 2014 | Pages 144-154

Authors

Kareem Mohamed

DS, MFDS RCS(Ed)

Senior House Officer in Oral and Maxillofacial Surgery, University Hospitals Bristol

Articles by Kareem Mohamed

Julian Yates

BSc, BDS, PhD, MFDS RCPS, FDS RCPS, FDS RCS

Professor of Oral and Maxillofacial Surgery, School of Dentistry, University of Manchester

Articles by Julian Yates

Anthony Roberts

BSc, BDS, FDS, FDS(Rest Dent), PhD

Clinical Lecturer in Periodontology Birmingham Dental School

Articles by Anthony Roberts

Abstract

The prevalence of diabetes is increasing significantly and, therefore, dental practitioners are having to manage diabetic patients on a more regular basis. Alongside the systemic effects on the various tissues and organs of the body, diabetes can adversely affect oral health and all clinicians should be aware of the issues that may arise.

Clinical Relevance: Dental practitioners are almost guaranteed to encounter both diagnosed and undiagnosed diabetic patients. It is therefore important that they are aware of the oral signs and symptoms of disease and the reciprocal relationship between oral health and glycaemic control, so that diabetic patients are managed accordingly.

Article

Diabetes mellitus describes a metabolic disorder of multiple aetiologies, primarily affecting the utilization of carbohydrates. It is a chronic disease recognized by hyperglycaemia secondary to insufficient insulin production by the pancreas or inability of the body to utilize the insulin it produces effectively.1 Depending on the pathogenesis, diabetes mellitus may be classified as Type 1 or Type 2.

Type 1 diabetes mellitus is a deficiency of insulin secretion, usually due to auto-immune damage of pancreatic β-cells. It is considered to be a condition of the young as the peak onset is around puberty and usually starts to affect patients of less than 20 years of age. It accounts for 10% of all diabetic cases and higher rates of the condition are found in Caucasians, especially those of North European origin.2,3

Type 2 diabetes mellitus describes a condition of insulin resistance, where the utilization of endogenously produced insulin at target cells is altered. Auto-immune destruction of β-cells does not usually occur and, although patients retain the capacity for insulin production, it may be reduced in some instances.4 The condition most often presents in middle and older age, although it is now more frequently diagnosed in younger overweight individuals. Type 2 represents 90% of all cases of diabetes mellitus in the UK and is up to three times more common among those of Asian, African or Afro-Caribbean decent.3,5

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available